We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Provexis Plc | LSE:PXS | London | Ordinary Share | GB00B0923P27 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.65 | 0.60 | 0.70 | - | 24,856 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Food Preparations, Nec | 390k | -385k | -0.0002 | -32.50 | 14.42M |
Date | Subject | Author | Discuss |
---|---|---|---|
29/12/2023 11:58 | Aye, leaving it to the last day is poor investor relations. Not having it ready before the market opens is even worse. There may be a good reason for today's tardiness, but when you have a history of being on the last minute for no good reason, then there's less goodwill knocking about. | bareknee | |
29/12/2023 11:42 | The company that never fails to disappoint - always the eleventh hour with the results.When you are receiving top $ remuneration is it so much to ask to get the results out in a timely manner? | redprince | |
09/12/2023 11:15 | BB - agree that Sirco is not going to make us much money - just good to see that MM still consider it worthwhile even after 5 years. Wewillwin - there is no chance of a p&d here - that ship sailed many years ago. | redprince | |
07/12/2023 15:56 | Pump n dump then placing | wewillwin20 | |
06/12/2023 07:22 | I agree BB. Although there is a massive market for drinkable yogurt it will take a fair bit of effort to compete with the likes of cholesterol lowering Benecol or even the supermarkets own brands of yogurt drinks proven to lower cholesterol. Will having the added benefit of Healthy Blood Flow (Fruitflow) and immunity support give it the edge? Who knows, but if its priced correctly and gets a good marketing campaign then hopefully we are both wrong :) If they had launched 5 years ago, like we expected, we would know by now. | gix er | |
05/12/2023 19:44 | Even in it's new format, I can't see Sirco being anything close to commercially successful enough to make much of an impact on our top and bottom lines, but it would be great to be wrong. Unless there's some other active ingredients, claiming efficacy on cholesterol is a weird one. AFAIK the UK is still bound by the same pre-Brexit situation on health claims. | bareknee | |
05/12/2023 18:37 | We can only hope so redprince. They have had over 5 years since they were planning to launch the last time. Wonder if the new agreement with DSM has made the difference or if its still a DSM premix/market ready solution? | gix er | |
05/12/2023 17:59 | Well done gixer (again) and great to see - will they have the marketing campaign that they promised for the last one that didn't launch? I certainly hope so - with the right push this could be really big but as ever the public need educating. Ballsy move in the current economic climate. | redprince | |
05/12/2023 12:51 | Great find | winner31 | |
05/12/2023 12:22 | www.sircoheart.com/ | gix er | |
05/12/2023 12:22 | redprince, [...] | gix er | |
17/11/2023 13:14 | You have to consider that he is a terrible investor IMO. Lucas has held here for how long ? | nestoframpers | |
13/11/2023 21:14 | Winner Unless there's something in the Company's Articles about it, I think you might be wrong about asking for a seat on the board if you hold > 10% ? In reality, given the size of his current holding and his support on recent fund raises, if Lucas wanted to be on the board, then it would be very difficult to deny him. More importantly, holding 10% or more becomes important in a takeover situation. If you hold 10% plus, you can block a bidder taking full control of a company. Basically, to fully take control of a company you need to hold 90% of the shares, If you control 50%, you can unilaterally appoint a board and run the company as you see fit, but until you get to 90% you can't force shareholders to sell up to you. So, at between 50 and 90% a bidder could take the company private, but they could still be left with minority shareholders on the register. To my, admittedly simple, mind, that means there is at least one good reason why Lucas and family would go to 10% plus, though doubtless he'll have good reasons for not doing so. | bareknee | |
05/11/2023 17:23 | Agree with you on that , I wonder if he’s pulling the strings on funding ! I’m sure he wouldn’t want his holding diluted the same as the rest of us . | winner31 | |
05/11/2023 09:52 | winner you are probably correct re SL.I suspect it was he who triggered the previous rns about Buck's past and then pressed for Buck to have a reduced role. If he has no designs on taking us private his presence here can only be a good thing. Smaller holders like ourselves have no meaningful way of holding the board to account. | redprince | |
04/11/2023 14:28 | I am very aware of the dangers from a large private shareholder ,but I believe he has held below 10% stake for a reason ,it is my belief that a holder with 10% of a company can ask for a seat on the board if they so wish ! maybe with his 9.85% he can hold the board to account without having a board seat , I do think if things don’t work out with by- health as planed he might have more of a say , just speculation at the moment .of course I am hoping By health get the Samr approval pretty quick and we can move on . | winner31 | |
04/11/2023 13:38 | winner - a word of caution on our main share holder - a lot of people took a false sense of comfort when the lawyer bought a significant holding in the company years ago.Stuart Lucas is in this for what he can make same as the rest of us - he could try and take this private and it may not be at a price that some are happy with. So that underlines why i would not entertain any talk of a t/o until we can see the income from By-Health after a year of sales. Hopefully SL is in this for the long term and that is very much in our better interests as if so he would help us to steer clear of a cheeky early doors offer. Aimvho. | redprince | |
04/11/2023 10:58 | Rp agree with you that we need sales from by health to get the share price moving ,and then a true value of the company can be made , unfortunately it won’t be up to us when and if a bid might come , I do think SL is in for the long term as he has just bought more at around .65p so hopefully won’t be tempted by a cheap offer . , When you look at what By-health have done with life space they must be looking for that sort of income from ff and maybe more ! What portion of that income comes to us nobody knows. | winner31 | |
04/11/2023 08:58 | winner - what i meant by that was that once By-Health come on line we need a year of sales to actually see what this deal looks like.Right now we are worth the value of our patents ie the cost/investment made in them so far.After a year of By-Health sales i should hope we are valued significantly higer and any t/o offer wouldl have to reflect not only current sales but factor in a good chunk of goodwill for future growth. So i clearly do not see any merit in talking about a t/o in the short or even medium term. | redprince | |
01/11/2023 16:24 | Rp what do you consider a”cheap buy out “ , consider that I think total t/o including dsm’s income ,is about £1m at the moment ,and bearing in mind the repeated paragraph “ substantial multiples of current income” and also it seems the pixes who turned up at the AGM were discussing a takeover ( informal I know) for them to even talk about this at this time must mean they would consider it after such a long time invested !. Interesting few months coming up I think imho | winner31 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions